Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Amicus Therapeutics, Inc. (FOLD) had Return on Equity of -37.05% for the most recently reported fiscal quarter, ending 2024-03-31.
Income Statement Financials | |
$110.40M |
|
$-48.42M |
|
$13.57M |
|
$96.84M |
|
$138.12M |
|
$-27.72M |
|
$-15.86M |
|
$-43.58M |
|
$-43.58M |
|
$-48.42M |
|
$-48.42M |
|
$-48.42M |
|
$-48.42M |
|
$-27.72M |
|
$-25.04M |
|
302.90M |
|
302.90M |
|
$-0.16 |
|
$-0.16 |
|
Balance Sheet Financials | |
$431.24M |
|
$32.42M |
|
$290.55M |
|
$721.79M |
|
$142.10M |
|
$388.39M |
|
$448.99M |
|
$591.10M |
|
$130.69M |
|
$-86.78M |
|
$130.69M |
|
296.16M |
|
Cash Flow Statement Financials | |
$-29.70M |
|
$7.54M |
|
$-13.31M |
|
$250.08M |
|
$212.79M |
|
$-37.28M |
|
$30.80M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
3.03 |
|
-- |
|
-- |
|
0.75 |
|
2.97 |
|
87.71% |
|
-25.11% |
|
-25.11% |
|
-- |
|
-39.48% |
|
-43.86% |
|
$-31.51M |
|
-- |
|
-- |
|
-- |
|
0.15 |
|
0.22 |
|
1.44 |
|
62.31 |
|
Return on Equity |
-37.05% |
55.80% |
|
-6.71% |
|
-9.33% |
|
$0.44 |
|
$-0.10 |
|
$-0.10 |